Gestational diabetes mellitus (GDM) is a condition characterized by high blood sugar levels that develop or are first diagnosed during pregnancy [5]. The global rates of GDM are on the rise, a trend often associated with increasing rates of obesity [1]. While many women with GDM may not experience noticeable symptoms, the condition is recognized as a significant metabolic event with potential implications for both maternal and offspring health across their lifespans [5].
Understanding Gestational Diabetes
During pregnancy, a woman's body naturally experiences increased insulin resistance, primarily driven by placental hormones and immune system changes. By the third trimester, insulin sensitivity can decrease by 60-65% [5]. To maintain normal blood sugar levels, the pancreas must significantly increase insulin production, sometimes by 200-250%. GDM occurs when the pancreatic beta-cells cannot meet this increased demand, leading to elevated blood glucose [5].
It's important to distinguish GDM from other conditions. For instance, gestational diabetes insipidus (GDI) is a rare and distinct condition involving water balance, not blood sugar, and is often underdiagnosed because increased urination can be mistaken for a normal pregnancy symptom [4]. Similarly, monogenic diabetes types, such as glucokinase-related MODY (GCK-MODY), are genetic forms of diabetes that require personalized management during pregnancy [6].
Why Screening for GDM is Crucial
GDM is more than a temporary condition; it's considered a "sentinel metabolic event" that can reveal pre-existing issues with insulin function [5]. Proper screening, diagnosis, and management are essential due to the substantial health risks involved [1].
- For the Mother: GDM indicates underlying defects in beta-cell function and insulin action, which can increase the risk of developing type 2 diabetes later in life [5].
- For the Baby: Maternal hyperglycemia can lead to fetal hyperinsulinemia, promoting accelerated fetal growth, increased fat storage (adipogenesis), and adverse metabolic programming. These effects can have intergenerational consequences, impacting the child's cardiometabolic health throughout their life [5].
Despite the clear need for screening, uptake can sometimes be a challenge, particularly in remote communities where access to healthcare may be limited [3].
How GDM is Screened
There is a unanimous consensus that GDM warrants screening, but the most optimal screening regimen remains a topic of discussion among medical professionals worldwide [1]. In the United States, for example, the American College of Obstetrics and Gynecology (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) generally recommend a two-step screening approach [1].
Recently, multiple studies have been published comparing the one-step and two-step screening processes, evaluating their impact on GDM incidence and perinatal outcomes. These ongoing comparisons aim to determine the most effective and efficient screening techniques [1].
Managing Gestational Diabetes
Once diagnosed, managing GDM typically involves a combination of dietary adjustments, regular physical activity, and careful monitoring of blood sugar levels. For some women, medication may be necessary to achieve optimal glycemic control.
A systematic review and meta-analysis found that combining metformin with insulin therapy, compared to insulin alone, was associated with a reduced risk of stillbirth for pregnant women with GDM or type 2 diabetes [8]. This suggests that a combination approach can be an effective and safe treatment option for managing blood sugar levels during pregnancy [8].
Addressing the Psychological Impact
Beyond the metabolic challenges, a diagnosis of GDM can often lead to anxiety, depression, and diabetes-specific distress [2]. This psychological stress can activate the body's stress response system, potentially worsening insulin resistance and making glycemic regulation more difficult, creating a "psychometabolic vicious cycle" [2].
Mindfulness-Based Stress Reduction (MBSR) is an evidence-based intervention known to help with emotional regulation and stress resilience. While MBSR has shown benefits in managing type 2 diabetes, its specific effectiveness on glycemic control and psychological well-being in GDM is currently being rigorously examined in clinical trials. One such trial is investigating an 8-week group-based MBSR program as an adjunct to routine antenatal care for pregnant women with GDM [2].
Long-Term Outlook After GDM
The implications of GDM extend beyond pregnancy. It serves as an important indicator of future health risks for both the mother and her child [5]. Women who have had GDM have an increased risk of developing type 2 diabetes later in life, and their children may also face a higher risk of metabolic issues. Therefore, continued monitoring and maintaining a healthy lifestyle after pregnancy are important steps for long-term well-being.
Sources
- Routine screening for gestational diabetes: a review. (Current opinion in obstetrics & gynecology, 2024)
- Mindfulness-Based Stress Reduction as an Adjunct Therapy for Gestational Diabetes Mellitus: A Randomized Controlled Trial Protocol. (Diabetes, metabolic syndrome and obesity : targets and therapy, 2026)
- Screening for hyperglycaemia in pregnancy and pregnancy outcomes among Aboriginal women in remote communities of the Northern Territory, Australia: a retrospective cohort study. (BMJ open, 2026)
- Gestational diabetes insipidus: a review of an underdiagnosed condition. (Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2010)
- How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic Future. (Diabetes, obesity & metabolism, 2026)
- Personalized management of glucokinase-related monogenic diabetes (GCK-MODY) during pregnancy: a case report. (Frontiers in endocrinology, 2026)
- Increasing Type 2 Diabetes Screening and Treatment Rates at a Community Clinic. (Journal of doctoral nursing practice, 2026)
- Metformin + Insulin vs. Insulin for GDM and T2DM during pregnancy: systematic review and meta-analysis. (Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2026)